Explorer les evidences

99 %None of the 5 rapid assays and only 1 ELISA reached the current WHO/UNAIDS recommendations on performance of HIV tests of at least 99% sensitivity and 98% specificity.

CamerounVIH/sidapublié 2009PloS oneeurope_pmcdocument de 6 observations

23 %Lesotho's adult HIV prevalence is 23%.

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

The prevalence of diabetes mellitus is higher in HIV-positive persons with associated hepatitis C virus (HCV) co-infection.

Cameroundiabète (non précisé) · hepatitis C virus (HCV) co-infection · VIH/sidapublié 2018Current diabetes reportseurope_pmcdocument de 2 observations

11,1 %The vertical transmission rate was 11.1% (17/153) among infants born to mothers not receiving ART.

CamerounVIH/sidaobservé November 2007 to October 2010publié 2019Paediatrics and international child healthPubMeddocument de 7 observations

88 %Overall, specificities of the evaluated HIV diagnostic tests were 88.0% to 98.8%.

CamerounVIH/sidapublié 2009PloS oneeurope_pmcdocument de 6 observations

3,2 per_100_person_yearsThe incidence rate of drug resistance was 3.2 per 100 person-years.

CamerounVIH/sidapublié 2005Antiviral TherapyOpenAlexdocument de 8 observationsDOI 10.1177/135965350501000208

4,9 %Among the 3956 rural villagers studied in Cameroon, the prevalence of HIV infection was 4.9%.

CamerounVIH/sidapublié 2010RetrovirologyOpenAlexdocument de 3 observationsDOI 10.1186/1742-4690-7-39

7,5 %HIV prevalence among women Armed Forces personnel of the Democratic Republic of Congo stationed in Kinshasa was 7.5% between June and September 2007.

CamerounVIH/sidaobservé June and September 2007publié 2015International journal of STD & AIDSeurope_pmcdocument de 6 observations

15,5 %Over 5,504 person-years, 577 patients were lost to follow-up (15.5%).

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

5 aOROn multivariate analysis, being small for gestational age was associated with an adjusted odds ratio of 5.0 (95% CI 2.4–10.3) for vertical HIV transmission.

CamerounVIH/sidaobservé November 2007 to October 2010publié 2019Paediatrics and international child healthPubMeddocument de 7 observations

2,31 hazard_ratioHIV-positive patients with hepatitis B co-infection had a hazard ratio of 2.31 for early antiretroviral treatment initiation.

Camerounhépatite B · VIH/sidaobservé 2014publié 2020Health Policy and PlanningOpenAlexdocument de 6 observationsDOI 10.1093/heapol/czaa153

2 specimensAmong 110 HIV-1-infected, drug-naïve Cameroonians, two major PI resistance-associated mutations (20M and 24I) were detected in only two specimens.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

1,3 %HIV prevalence in the general population of the Democratic Republic of Congo was 1.3%.

CamerounVIH/sidapublié 2015International journal of STD & AIDSeurope_pmcdocument de 6 observations

3,4 %58 patients (3.4%) in the hospital group had no follow-up visit.

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

68,5 %Among those testing HIV-positive, 68.5% (403) received CD4 testing.

CamerounVIH/sidapublié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

18,2 %Among 407 patients on first-line antiretroviral treatment in rural Cameroon, 74 (18.2%) had antiretroviral drug resistance.

CamerounVIH/sidaobservé 2013-2014publié 2016Open Forum Infectious DiseasesOpenAlexdocument de 5 observationsDOI 10.1093/ofid/ofw233

3,8 %The prevalence of HIV among Armed Forces personnel of the Democratic Republic of Congo stationed in Kinshasa was 3.8% between June and September 2007.

CamerounVIH/sidaobservé June and September 2007publié 2015International journal of STD & AIDSeurope_pmcdocument de 6 observations

2 323 adults2,323 adults (74% of the community) participated in the campaign.

CamerounVIH/sidaobservé 2011publié 2012Journal of the International AIDS Societyeurope_pmcdocument de 39 observations

12 %The prevalence of the 64M substitution in protease sequences was 12% (7/57) among 57 HIV-1-infected treatment-naive individuals from Cameroon.

CamerounVIH/sidapublié 2011AIDS Research and Human RetrovirusesOpenAlexdocument de 24 observations

93,3 %93.3% of participants on antiretroviral treatment were receiving first-line regimen.

CamerounVIH/sidapublié 2017Tropical diseases, travel medicine and vaccineseurope_pmcdocument de 8 observations

65 %Versions 1.0, 1.0+, and 1.5 detected 65, 98, and 100% of the subtype A-infected samples from patients, respectively.

CamerounVIH/sidapublié 1999Journal of Clinical MicrobiologyOpenAlexdocument de 6 observationsDOI 10.1128/jcm.37.1.110-116.1999

2 %Among 301 strains in a global collection, 7 (2%) had unclassifiable protease (PR) sequences.

CamerounVIH/sidapublié 2002Journal of Clinical MicrobiologyOpenAlexdocument de 12 observations

The prevalence of hypertension was significantly increased with duration of highly active antiretroviral therapy (HAART) in HIV-infected Cameroonians.

CamerounVIH/sidapublié 2013Diabetes & metabolismeurope_pmcdocument de 12 observations

40,9 %Among patients with NRTI resistance, 18/44 (40.9%) carried Thymidine Analog Mutations (TAMs).

CamerounVIH/sidapublié 2013Journal of the International AIDS SocietyOpenAlexdocument de 3 observationsDOI 10.7448/ias.16.1.18004

2,05 RRAmong 10,615 individuals in sub-Saharan Africa, anti-retroviral therapy was associated with a two-fold higher probability of raised triglycerides (>2.3 mmol/L), with a relative risk of 2.05.

CamerounVIH/sidaobservé 2003–2014publié 2018Global health, epidemiology and genomicseurope_pmcdocument de 2 observations